Skip to content
Pharma Two B logo — Clinical stage pharma company striving to improve patients q...

Pharma Two B

Clinical stage pharma company striving to improve patients quality of life by developing innovative combination products

Founded 2007 Israel Israel 7 employees Series C Total: $38.00M Biopharma, Biotechnology +1

General Information

Company Name Pharma Two B
Founded Year 2007
Location Israel Israel
Employees 7
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Pharma Two B. To contact Pharma Two B, visit pharma2b.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pharma Two B compare?

A PDF of Pharma Two B and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pharma Two B soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pharma Two B

Pharma Two B is a clinical-stage pharma company with a focus on developing innovative combination products to enhance the quality of life for patients. The company leverages its expertise to identify and characterize potential synergistic drug combinations, aiming to deliver heightened therapeutic effects with improved safety profiles. Pharma Two B's primary goal is to address unmet medical needs by creating clinically meaningful and safe combination products. Their lead investigational product, P2B001, has completed successful Phase IIb and Phase III studies for the treatment of early Parkinson’s Disease (PD). Founded in 2007 and headquartered in Israel, the company secured a significant $30.00M Series C investment in February 27, 2017 from investors including JK&B Capital, Israel Biotech Fund, JVC, and Generali Financial Holding. Pharma Two B's efforts in developing novel pharmaceutical solutions, particularly in the biopharma, biotechnology, and pharmaceutical industries, showcase its potential for significant impact in the healthcare sector.

Business keywords: Pharma, Drug Development, Clinical Trials, Parkinson's Disease, Cancer, Combination Products, Therapeutic Innovation, Clinical Stage, Regulatory Pathways, Patient Advocacy, Fixed-Dose Combinations, Synergistic Effects, Unmet Medical Needs, Value-added Products

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $30.00M 4
JK&B Capital, Israel Biotech Fund +2
27 Feb 2017
Series B $8.00M 2
JK&B Capital, Michael Mittelman
23 Oct 2012

Pharma Two B Alternatives & Competitors

View All Alternatives
Pharma Two B vs
Genmab
Genmab Denmark

Differentiated human antibody therapeutics for the treatment of cancer

IPO
3102 employees
Biotechnology, Pharmaceutical
Pharma Two B vs

Aclipse develops novel and highly differentiated therapeutics to treat diseases with significant unm...

Grant
10 employees
Biotechnology, Pharmaceutical
Pharma Two B vs

Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on...

Post-IPO Equity
9 employees
Biopharma, Biotechnology

FAQ About Pharma Two B

Clinical stage pharma company striving to improve patients quality of life by developing innovative combination products
Pharma Two B was founded in 2007.
Pharma Two B is headquartered in Israel.
Pharma Two B operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on Pharma, Drug Development, Clinical Trials and Parkinson's Disease.
Pharma Two B has approximately 7 employees.
Pharma Two B has completed 2 funding rounds, raising a total of $38.00M. The latest funding stage is Series C.
Top alternatives and competitors to Pharma Two B include Genmab, Aclipse Therapeutics, Minerva Neurosciences, PaxMedica, Inc., Calluna Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pharma Two B and Genmab are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pharma Two B, https://bouncewatch.com/company/pharma-two-b, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout